UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection

Infection, 2022-04, Vol.50 (2), p.295-308

2022

Volltextzugriff (PDF)

Immunotoxins in cancer therapy: Review and update

International reviews of immunology, 2017-07, Vol.36 (4), p.207-219

2017

Volltextzugriff (PDF)

Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study

Biológia, 2023-10, Vol.78 (10), p.3001-3001

2023

Volltextzugriff (PDF)

Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study

Biológia, 2022-08, Vol.77 (8), p.2269-2280

2022

Volltextzugriff (PDF)

Evolution of phage display technology: from discovery to application

Journal of drug targeting, 2017-03, Vol.25 (3), p.216-224

2017

Volltextzugriff (PDF)

Anti-cancer Immunotoxins, Challenges, and Approaches

Current pharmaceutical design, 2021-01, Vol.27 (7), p.932-941

2021

Volltextzugriff (PDF)

MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications

Current molecular medicine, 2023-01, Vol.23 (7), p.648-667

2023

Volltextzugriff (PDF)

Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa

BMC infectious diseases, 2021-03, Vol.21 (1), p.300-300, Article 300

2021

Volltextzugriff (PDF)

In silico Validation of Pseudomonas aeruginosa Exotoxin A Domain I Interaction with the Novel Human scFv Antibody

Infectious disorders drug targets, 2023, Vol.23 (5), p.e290323215113

2023

Volltextzugriff (PDF)

Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics

Anti-cancer agents in medicinal chemistry, 2022-01, Vol.22 (10), p.2026-2035

2022

Volltextzugriff (PDF)

New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update

Anti-cancer agents in medicinal chemistry, 2021-01, Vol.21 (1), p.3-19

2021

Volltextzugriff (PDF)

Critical Point Mutations in the RBD of SARS-COV-2 Involved in Binding to ACE2

Molecular genetics, microbiology and virology, 2024-03, Vol.39 (1), p.86-94

2024

Volltextzugriff (PDF)

The high cross-transmission in methicillin resistant Staphylococcus aureus between healthy and patient communities

Iranian journal of microbiology, 2023-06, Vol.15 (3), p.408-413

2023

Volltextzugriff (PDF)

Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran

BMC research notes, 2019-05, Vol.12 (1), p.260-260, Article 260

2019

Volltextzugriff (PDF)

The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units

Iranian journal of microbiology, 2022-06, Vol.14 (3), p.319-327

2022

Volltextzugriff (PDF)

Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology

Current pharmaceutical design, 2017-01, Vol.23 (13), p.2009-2014

2017

Volltextzugriff (PDF)

Prevalence of Human Papillomavirus in Patients With Oral Squamous Cell Carcinoma in Tabriz, Iran

Crescent journal of medical and biological sciences, 2019-01, Vol.6 (1), p.105-108

2019

Volltextzugriff (PDF)

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology

Advanced pharmaceutical bulletin, 2016-12, Vol.6 (4), p.563-571

2016

Volltextzugriff (PDF)

Rational design of hybrid peptide with high antimicrobial property derived from Melittin and Lasioglossin

Journal of biomolecular structure & dynamics, 2023-10, p.1-9

2023

Volltextzugriff (PDF)

Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery

Drug discovery today, 2024-11, Vol.29 (11), p.104191, Article 104191

2024

Volltextzugriff (PDF)

Yeast Expression Systems: Overview and Recent Advances

Molecular biotechnology, 2019-05, Vol.61 (5), p.365-384

2019

Volltextzugriff (PDF)

Immobilized recombinant laccase over PEGylated silica-coated magnetic nanoparticles for anti-inflammatory modulation in pro-monocytic model cell line

Process biochemistry (1991), 2024-11, Vol.146, p.56-67

2024

Volltextzugriff (PDF)

Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction

Journal of molecular structure, 2023-01, Vol.1272, p.134160-134160, Article 134160

2023

Volltextzugriff (PDF)

Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update

Molecular biotechnology, 2024-06

2024

Volltextzugriff (PDF)

Bio-nano scale modifications of melittin for improving therapeutic efficacy

Expert opinion on biological therapy, 2022-07, Vol.22 (7), p.895-909

2022

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(14)
Biotechnology & Applied Microbiology
(12)
Biochemistry & Molecular Biology
(11)
Microbiology
(9)
Pharmacology & Pharmacy
(9)
Immune Response
(6)
Animals
(5)
Biomedical And Life Sciences
(5)
Cell Biology
(5)
Genetics & Heredity
(5)
Infectious Diseases
(5)
Life Sciences
(5)
Phage Display
(5)
Antibiotics
(4)
Antibodies
(4)
Cancer
(4)
Human Single Chain Antibody
(4)
Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection

Immunotoxins in cancer therapy: Review and update

Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study

Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study

Evolution of phage display technology: from discovery to application

Anti-cancer Immunotoxins, Challenges, and Approaches

MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications

Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa

In silico Validation of Pseudomonas aeruginosa Exotoxin A Domain I Interaction with the Novel Human scFv Antibody

Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics

New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update

Critical Point Mutations in the RBD of SARS-COV-2 Involved in Binding to ACE2

The high cross-transmission in methicillin resistant Staphylococcus aureus between healthy and patient communities

Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran

The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units

Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology

Prevalence of Human Papillomavirus in Patients With Oral Squamous Cell Carcinoma in Tabriz, Iran

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology

Rational design of hybrid peptide with high antimicrobial property derived from Melittin and Lasioglossin

Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery

Yeast Expression Systems: Overview and Recent Advances

Immobilized recombinant laccase over PEGylated silica-coated magnetic nanoparticles for anti-inflammatory modulation in pro-monocytic model cell line

Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction

Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update

Bio-nano scale modifications of melittin for improving therapeutic efficacy

Suchergebnisse filtern